IT1143922B - 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione - Google Patents

4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione

Info

Publication number
IT1143922B
IT1143922B IT48997/80A IT4899780A IT1143922B IT 1143922 B IT1143922 B IT 1143922B IT 48997/80 A IT48997/80 A IT 48997/80A IT 4899780 A IT4899780 A IT 4899780A IT 1143922 B IT1143922 B IT 1143922B
Authority
IT
Italy
Prior art keywords
aroilimidazol
oni
cardiotonic
thrombotic
procedure
Prior art date
Application number
IT48997/80A
Other languages
English (en)
Italian (it)
Other versions
IT8048997A0 (it
Inventor
Richard A Schnettler
Richard C Dage
J Martin Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1143922(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of IT8048997A0 publication Critical patent/IT8048997A0/it
Application granted granted Critical
Publication of IT1143922B publication Critical patent/IT1143922B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT48997/80A 1979-06-18 1980-06-17 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione IT1143922B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
IT8048997A0 IT8048997A0 (it) 1980-06-17
IT1143922B true IT1143922B (it) 1986-10-29

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48997/80A IT1143922B (it) 1979-06-18 1980-06-17 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione

Country Status (20)

Country Link
AT (1) AT375349B (xx)
AU (1) AU532783B2 (xx)
CA (1) CA1132554A (xx)
CH (1) CH646155A5 (xx)
DE (1) DE3021792A1 (xx)
DK (1) DK160269C (xx)
ES (1) ES8105299A1 (xx)
FR (1) FR2459233A1 (xx)
GB (1) GB2055364B (xx)
HK (1) HK61486A (xx)
HU (1) HU186736B (xx)
IE (1) IE50646B1 (xx)
IL (1) IL60243A (xx)
IT (1) IT1143922B (xx)
MY (1) MY8600709A (xx)
NL (2) NL193752C (xx)
NO (1) NO152841C (xx)
NZ (1) NZ193935A (xx)
PH (1) PH18683A (xx)
SE (2) SE447107B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
ZA822990B (en) * 1981-05-04 1983-03-30 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2005092333A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NL8003498A (nl) 1980-12-22
HK61486A (en) 1986-08-29
NO152841B (no) 1985-08-19
CA1132554A (en) 1982-09-28
MY8600709A (en) 1986-12-31
DE3021792A1 (de) 1981-01-22
NL193752C (nl) 2000-09-04
HU186736B (en) 1985-09-30
ES492255A0 (es) 1981-06-01
IT8048997A0 (it) 1980-06-17
CH646155A5 (de) 1984-11-15
IE801162L (en) 1980-12-18
GB2055364A (en) 1981-03-04
SE464559B (sv) 1991-05-13
DK160269B (da) 1991-02-18
NO801796L (no) 1980-12-19
SE447107B (sv) 1986-10-27
SE8004253L (sv) 1980-12-19
GB2055364B (en) 1983-06-08
IL60243A (en) 1987-01-30
AU532783B2 (en) 1983-10-13
SE8501452D0 (sv) 1985-03-25
NO152841C (no) 1985-11-27
IE50646B1 (en) 1986-06-11
AT375349B (de) 1984-07-25
ES8105299A1 (es) 1981-06-01
NL193752B (nl) 2000-05-01
AU5911880A (en) 1981-01-08
DE3021792C2 (xx) 1989-08-10
PH18683A (en) 1985-08-29
FR2459233A1 (fr) 1981-01-09
ATA314280A (de) 1983-12-15
NL300015I1 (nl) 2000-11-01
DK160269C (da) 1991-07-22
FR2459233B1 (xx) 1983-09-23
NZ193935A (en) 1985-05-31
DK259080A (da) 1980-12-19
IL60243A0 (en) 1980-09-16
NL300015I2 (nl) 2000-10-02
SE8501452L (sv) 1985-03-25

Similar Documents

Publication Publication Date Title
IT1143922B (it) 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione
IT1188908B (it) Composti eterociclici dotati di proprieta' farmacologiche e procedimento per la loro preparazione
IT1144079B (it) Nuovi derivati piperidinici dotati di proprieta' antiistaminiche antiallergiche e broncodilatatrici e procedimento per la loro preparazione
IT8024229A0 (it) Composizioni vulcanizzabili erelativo procedimento.
IT8148261A0 (it) Ammidi dotate di proprieta' farmaceutiche e loro preparazione
IT1171520B (it) Procedimento per la preparazione di 2-ammino-3-carbetossiammino-6-(p-fluor-benzilammino)-piridin-maleato dotato di proprieta' farmacologiche e prodotto ottenuto
IT8047580A0 (it) Derivati di 1,2-diidro-2-osso-4-fe nil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
IT1141012B (it) "6-piridazioni utili come cardiotonici,e loro preparazione"
IT1142179B (it) Perfezionamento nei materiali di controllo termica particolarmente per l'isolamento di veicoli spaziali
IT8023649A0 (it) Procedimento per migliorare la proprieta' di leghe.
IT1131682B (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione
TR20746A (tr) Homoserin tuerevleri,bunlarin hazirlanisi icin usul ve bunlarin mikrobisidler olarak kullanilmalari
IT8083420A0 (it) Derivati d'amino-14 steroidi e procedimento per la loro preparazione.
IT1141392B (it) Procedimento di trasformazione dell'idrargillite in boemite
IT1143921B (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
IT1174296B (it) Derivati di tallisomicina semibiosintetici dotati di prorieta'antimicrobiche ed anti-tumorali e procedimento per la loro preparazione
ES491732A0 (es) Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol
IT1145339B (it) Acidi-6ammino-spiro(penam-2,4'-piperidino)-3-carbossilici e loro procedimento di preparazione
IT1148788B (it) Derivati dell'amminoisochinolina e procedimento per la loro preparazione
IT1130215B (it) 3-ariltio-4-idrossipirrolidine 1-sostituite e procedimento per la loro preparazione
IT1143941B (it) Derivati alfa-alogenometilamminici dotati di attivita' farmacologica e procedimento per la loro preparazione
BR8007615A (pt) Composicao vulcanizavel e composto
IT1130214B (it) 3, 4-epossipirrolidine 1-sostituite e procedimento per la loro preparazione
IT1164744B (it) Composti cicloalifatici dotati di proprieta' analgesiche e procedimento per la loro preparazione
IT1102595B (it) Benzomorfani sostitutti dotati di proprieta' farmacologiche e procedimento per la loro preparazione

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 156

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 156, 19920424; MERREL DOW PHARMACEUTICALS INC.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950419